Effects of TGF-beta Signalling Inhibition With Galunisertib (LY2157299) in Hepatocellular Carcinoma Models and in Ex Vivo Whole Tumor Tissue Samples From Patients
Oncotarget - United States
doi 10.18632/oncotarget.4308
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 28, 2015
Authors
Publisher
Impact Journals, LLC